← EU Feed

Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis

AI Briefing

  • Levicept Ltd presents data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
  • Positive results expected for LEVI-04 treatment for osteoarthritis of the knee
  • Levicept Ltd to showcase findings in West Palm Beach, FL
Advertisement
Read Original Article